Background:With increasing numbers of patients undergoing transcatheter aortic valve replacement(TAVR),data on management of failed TAVR,including repeat TAVR procedure,are needed.The aim of this study was to assess t...Background:With increasing numbers of patients undergoing transcatheter aortic valve replacement(TAVR),data on management of failed TAVR,including repeat TAVR procedure,are needed.The aim of this study was to assess the safety and efficacy of redo-TAVR in a national registry.Methods:This study included all consecutive patients in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry from Nov 9,2011,to Dec 30,2022 who underwent TAVR with balloon-expandable valves in failed transcatheter heart valves(redo-TAVR)or native aortic valves(native-TAVR).展开更多
文摘Background:With increasing numbers of patients undergoing transcatheter aortic valve replacement(TAVR),data on management of failed TAVR,including repeat TAVR procedure,are needed.The aim of this study was to assess the safety and efficacy of redo-TAVR in a national registry.Methods:This study included all consecutive patients in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry from Nov 9,2011,to Dec 30,2022 who underwent TAVR with balloon-expandable valves in failed transcatheter heart valves(redo-TAVR)or native aortic valves(native-TAVR).
